pubmed-article:18840986 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0546837 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0851346 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0231242 | lld:lifeskim |
pubmed-article:18840986 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:18840986 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:18840986 | pubmed:dateCreated | 2008-10-8 | lld:pubmed |
pubmed-article:18840986 | pubmed:abstractText | 5-Fluorouracil(5-FU)and cis-dichlorodiammineplatinum(CDDP)combined with 60Gy of radiation was administered to a 65-year-old man with advanced esophageal cancer complicated with chronic renal failure treated with hemodialysis(HD). Continuous infusion of 5-FU 680mg/m(2) on Days 1-5 and 8-12, and drip infusion of CDDP 40mg/m(2) on Days 1 and 8 were administered twice with a 5-week interval. The CDDP dosage was reduced to 40% and HD was started 30 minutes after CDDP administration. Concurrent radiotherapy was started on Day 1 at 2Gy/d for 5d/week. The concentration of both free CDDP and total CDDP was measured using the atomic absorption method after the second treatment period. The area under the curve(AUC)of free CDDP was 3.3microg x h/ml. Both Grade 4 anemia and Grade 3 leukopenia were observed, but the renal failure did not progress. All toxicities were tolerable and the CDDP dose reduction and HD method were appropriate for the patient. | lld:pubmed |
pubmed-article:18840986 | pubmed:language | jpn | lld:pubmed |
pubmed-article:18840986 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18840986 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18840986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18840986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18840986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18840986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18840986 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18840986 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18840986 | pubmed:issn | 0446-6586 | lld:pubmed |
pubmed-article:18840986 | pubmed:author | pubmed-author:AraiYokoY | lld:pubmed |
pubmed-article:18840986 | pubmed:author | pubmed-author:MiyataYoshino... | lld:pubmed |
pubmed-article:18840986 | pubmed:author | pubmed-author:OyamaTsuneoT | lld:pubmed |
pubmed-article:18840986 | pubmed:author | pubmed-author:TomoriAkihisa... | lld:pubmed |
pubmed-article:18840986 | pubmed:author | pubmed-author:HottaKinichiK | lld:pubmed |
pubmed-article:18840986 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18840986 | pubmed:volume | 105 | lld:pubmed |
pubmed-article:18840986 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18840986 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18840986 | pubmed:pagination | 1482-8 | lld:pubmed |
pubmed-article:18840986 | pubmed:dateRevised | 2011-8-2 | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:meshHeading | pubmed-meshheading:18840986... | lld:pubmed |
pubmed-article:18840986 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18840986 | pubmed:articleTitle | [Successful treatment with 5-fluorouracil and cis-dichlorodiammineplatinum combined with 60Gy of radiation in a case of advanced esophageal cancer complicated with chronic renal failure treated with hemodialysis]. | lld:pubmed |
pubmed-article:18840986 | pubmed:affiliation | Department of Gastroenterology, Saku Central Hospital. | lld:pubmed |
pubmed-article:18840986 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18840986 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:18840986 | pubmed:publicationType | Case Reports | lld:pubmed |